Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1081 - 1088 of 11616 results
FDA Warns “Natural” Birth Control Company: Three Takeaways from the NOV Letter
August 1, 2023| Blog| Viewpoint
What’s New in Wireless - August 2023
August 1, 2023| Blog| Viewpoint
SEC Adopts Final Cybersecurity Rules for Public Companies
August 1, 2023| Blog| Viewpoint
SEC Adopts Final Cybersecurity Rules for Public Companies
August 1, 2023| Blog| Viewpoint
USCIS Announces Second H-1B Cap Lottery
July 28, 2023| Alert| Viewpoint
Rising Medical Costs Force Greater Scrutiny Of Health M&A Deals
July 28, 2023| News
SEC Moves Quickly On Its 55-Part Rulemaking Agenda
July 27, 2023| Alert| Viewpoint
The White House’s Voluntary Framework for Ensuring Safe, Secure, and Trustworthy AI — AI: The Washington Report
July 27, 2023| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.